WallStreetZenWallStreetZen

NASDAQ: AVTX
Avalo Therapeutics Inc Stock Ownership - Who owns Avalo Therapeutics?

OverviewForecastEarningsDividendOwnership

Insider buying vs selling

Have Avalo Therapeutics Inc insiders been buying or selling?
Buy
Sell
NameRoleDateSharesPriceValue
Armistice Capital LLC10% Owner2023-06-27937,404$0.52
$486.51kSell
Caissa Capital Management Ltd10% Owner2023-06-26182,300$0.62
$113.03kSell
Armistice Capital LLC10% Owner2023-06-262,746,138$0.61
$1.68MSell
Caissa Capital Management Ltd10% Owner2023-06-261,425,700$0.64
$916.73kSell
Caissa Capital Management Ltd10% Owner2023-06-202,000$4.14
$8.29kBuy
Caissa Capital Management Ltd10% Owner2023-06-163,000$3.91
$11.72kBuy
Caissa Capital Management Ltd10% Owner2023-06-153,160$3.68
$11.64kBuy
Caissa Capital Management Ltd10% Owner2023-06-146,000$3.48
$20.87kBuy
Caissa Capital Management Ltd10% Owner2023-06-138,750$3.82
$33.44kBuy
Caissa Capital Management Ltd10% Owner2023-06-122,149$4.34
$9.32kBuy

1 of 3

AVTX insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when AVTX insiders and whales buy or sell their stock.

AVTX Shareholders

What type of owners hold Avalo Therapeutics Inc stock?
Institutional
Insider
Retail
NameHoldSharesValueType
Armistice Capital LLC4,991.17%51,615,185$494.99MInsider
Robert Moscato Jr.865.72%8,952,643$85.86MInsider
Randal Jones615.00%6,359,900$60.99MInsider
Steven Boyd226.83%2,345,714$22.50MInsider
Patrick J. Crutcher158.08%1,634,771$15.68MInsider
Apple Tree Partners Iv LP57.58%595,436$5.71MInsider
Mpm Bioventures V LP57.58%595,436$5.71MInsider
Patrick J. Kerins57.46%594,245$5.70MInsider
New Enterprise Associates 14 LP57.46%594,245$5.70MInsider
Scott D. Sandell57.46%594,245$5.70MInsider

1 of 3

AVTX vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
AVTX0.11%99.89%Net Selling
CHRO4.37%48.62%Net BuyingNet Buying
CANF0.04%0.00%
MTEM1.87%98.13%Net BuyingNet Buying
ONVO4.83%95.17%Net Selling
View Top Biotech Stocks

Avalo Therapeutics Stock Ownership FAQ

Who owns Avalo Therapeutics?

Avalo Therapeutics (NASDAQ: AVTX) is owned by 8.46% institutional shareholders, 7,850.36% Avalo Therapeutics insiders, and 0.00% retail investors. Armistice Capital LLC is the largest individual Avalo Therapeutics shareholder, owning 51.62M shares representing 4,991.17% of the company. Armistice Capital LLC's Avalo Therapeutics shares are currently valued at $494.99M.

If you're new to stock investing, here's how to buy Avalo Therapeutics stock.
©2024 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.